(Allergan plc)

	AGN latest price $166.0800 (0.14%) ($165.1600 - $167.2100) on Mon. Jul. 15, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	3.77% (three month average)
RSI	92
Latest Price	$166.0800(0.14%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.1% a day on average for past five trading days.
Weekly Trend	AGN advances 2.2% a week on average for past two weeks.
Market Behavior	Normal for large cap. Value stock sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IVW(82%)    IWF(82%)    XLV(82%)    IBB(81%)    SPY(81%)
Factors Impacting AGN price	AGN will decline at least -1.885% in a week (0% probabilities).   VXX(-69%)    VIXM(-61%)    TLT(-42%)    IFRA(-39%)    BWX(-13%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.885% (StdDev 3.77%)
Hourly BBV	0 ()
Intraday Trend	0.3%

5 Day Moving Average	$166.21(-0.08%)
10 Day Moving Average	$167(-0.55%)
20 Day Moving Average	$155.34(6.91%)
To recent high	-2.1%
To recent low	43.5%
Market Cap	$54.757b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed